The autoimmune thyroid diseases (AITD) comprise a series of interrelated conditions including Graves' disease (GD) and Hashimoto's thyroiditis (HT). AITD are the most prevalent diseases of the thyroid gland in the pediatric population, particularly in adolescence.
US ENDOCRINOLOGY is about 20 to 40 times higher than in the blood, since this element is essential to the synthesis of thyroid hormones. The process consists of the incorporation of iodine into tyrosine residues of Tg, leading to formation of derivatives of mono-and di-iodotyrosine, which subsequently undergo oxidation resulting in the production of the hormones T3 and T4. 15 Several studies suggest that the Tg iodization is crucial for recognition by the T cells and, on the other hand, the excess of iodine may affect the Tg molecule directly, by creating new epitopes or exposing cryptic epitopes. 16 
Pathogenesis
In the original description in 1912, Hashimoto described the histopathologic features of four thyroids with increased volume and a set of common histologic changes. These histologic changes included fibrosis, increasing number of oxyphilic cells (Hürthle), and diffuse lymphocytic infiltration, in which lymphocytes were organized in true lymphoid follicles with germinal centers, designating these changes as lymphoid transformation of thyroid or "goiter linfoadenomatoso." 17 There is no evidence that the ethiopathogenic mechanisms of HT in children and adolescents differs from those activated in adulthood. The currently accepted mechanism of pathogenesis of HT involves three stages. In the early phase, antigen presenting cells (APC), mainly dendritic cells and macrophages, infiltrate the thyroid gland (for details see Figure 1 )
The infiltration may be induced by an environmental factor (iodine, toxins, infectious agent), which causes cell damage and the exposure of thyrocytes specific proteins. These proteins serve as their own source of antigenic peptides that are presented on the cell surface of APC after processing.
Thyroid APC migrate to the lymph node where interactions occur between the APC cells, activated T cells, and B cells, leading to the induction of a variety of autoantibodies against thyroid-specific antigens.
In the next step, B lymphocytes, cytotoxic T cells, and macrophages infiltrate the thyroid. In this phase there is a clonal expansion of lymphocytes and propagation of lymphoid tissue in the thyroid gland. 17, 18 In the final stage, "autoreactive" T cells, B cells, and antibodies cause a massive destruction of the thyrocytes. In addition to cell-mediated immune mechanisms, HT is characterized by the production of antibodies against a variety of thyroid-specific antigens, such as thyroglobulin (TG) and peroxidase (TPO), but also the TSH receptor, sodium/iodine (NIS) symporter, 19 and pendrin has been recently reported.
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Hashimoto's Thyroiditis Disease Associations
HT in childhood and adolescence may appear combined with specific autoimmune diseases, namely autoimmune polyglandular syndrome (APS) 1 and 2 (see Table 1 ). APS-1, which is presented in the first decade of life, is caused by a mutation of a single gene (autosomal recessive defect in AIRE gene mapped to 21q22.3) and is characterized by the development of sequential mucocutaneous candidiasis, hypoparathyroidism, adrenal deficiency, and HT. 21 APS-2 tends to occur in the period of later childhood or adolescence, with Addison's disease in association with HT (Schmidt's syndrome) or AIT with DM1 (Carpenter syndrome). 22 Patients with a particular human leukocyte antigen genotype (HLA-DQ2, HLA-DQ8, and HLA-DR4) are at a higher risk for developing APS-2. The HT was also described in children with immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX syndrome), a polyglandular alteration characterized by early onset diabetes and colitis, linked to the dysfunction of the transcription factor FOXP3. 23 HT can coexist with other organ-specific autoimmune diseases, particularly diabetes mellitus type 1. There is a greater incidence of HT in patients with certain chromosomal alterations such as Down syndrome, 24 Turner syndrome, 25 and Klinefelter syndrome. The AITD may also be associated with chronic urticaria 26 and, rarely, glomerulonephritis.
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Clinical Manifestations
Thyroid hormones play an important role in childhood growth and are involved in the maturation and metabolism of certain organs such as the skeleton and brain where they influence the process of myelination of the nervous system. 28 One of the biggest differences between HT presentation 
cells, B cells, and antibodies cause massive depletion of thyrocytes via antibody-dependent, cytokinemediated, and apoptotic mechanisms of cytotoxity that leads to hypothyroidism. b) Apoptosis regulation in thyroid (Arscott and Baker, 1998 adapted). CD4 = cluster of differentiation 4; CD8 = cluster of differentiation 8; DR3 = decoy receptor 3; FLICE = DED (FADD) containing procaspase-8; FADD = Fas-associated death domain ; TNF = tumor necrosis factor; TRADD = TNF receptor associated death domain; TRAIL = TNF related apoptosis inducing ligand.
Adapted from Arscott and Baker, 1998 38 in childhood and adults remains in the fact that HT hypothyroidism may lead to short stature, decline in school performance, and retardation of development, which have effects in adult life. 29 Males normally have an increased testicular volume and rising levels of prolactin and TSH. Several authors consider the possibility of association between pseudopuberty and hypothyroidism due to cross-reactivity between high TSH and FSH receptors. 32 The female adolescent may experience an associated precocious puberty and/or polycystic ovaries. 33 Some adolescents may have clinical manifestations characteristic of hyperthyroidism such as nervousness, irritability, sweating, behavioral hyperactivity, without laboratory evidence of hyperthyroidism.
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Diagnosis
The determination of serum TSH concentration is the best screening test for primary hypothyroidism. If the TSH is high, the assessment of the serum free thyroxine (fT4) concentration will tell if the child has subclinical hypothyroidism (normal fT4) or hypothyroidism (low fT4).
Diagnosis also includes positivity for anti-TPO autoantibodies and/or anti- stabilize the TSH value within the desired range. 31 The levothyroxine doses may need to be adjusted depending on the laboratory variations, in order to avoid the onset of symptoms of overdose as agitation, insomnia, flushing, diarrhoea, sweating, or tachycardia. 33 Since the biochemical euthyroid status is reached, TSH should be monitored every 4-6 months in children and adolescents.
Levothyroxine should be administered at least 20 minutes before eating or drinking any medication, since it interferes with the absorption of calcium and iron as well as the potassium exchange, aluminium-containing antiacids, bile acid resins linker.
Surgical therapy (thyroidectomy) is recommended only in cases of suspected malignancy coexistence or to relieve compressive symptoms (dysphagia, cough, dyspnea, hoarseness) in patients with large goiters. 37 The treatment of children and adolescents with subclinical hypothyroidism (normal fT4, high TSH) is controversial. The long-term follow-up studies of children with subclinical hypothyroidism due to AIT suggested a significant likelihood of remission. Consequently, if there is a strong family history of hypothyroidism and if the patient is not symptomatic, a reasonable option is to re-evaluate thyroid function every 6 months.
Conclusion
Adolescents who display thyroid enlargement should always be evaluated for HT and thyroid function. Although most children with HT remain euthyroid during their lives, thyroid function should be monitored periodically for early detection and treatment hypothyroidism. ■ 
